Tandem Isotope Therapy with (225)Ac- and (177)Lu-PSMA-617 in a Murine Model of Prostate Cancer

Radionuclide therapy targeting prostate-specific membrane antigen (PSMA) is a promising option for metastatic castration-resistant prostate cancer. Clinical experience using (177)Lu or (225)Ac has demonstrated encouraging treatment responses; however, responses are not durable. Dual-isotope combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Catherine, Stuparu, Andreea, Lueckerath, Katharina, Calais, Jeremie, Czernin, Johannes, Slavik, Roger, Dahlbom, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2023
Materias:
Basic Science Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626377/
https://www.ncbi.nlm.nih.gov/pubmed/37797974
http://dx.doi.org/10.2967/jnumed.123.265433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626377/
https://www.ncbi.nlm.nih.gov/pubmed/37797974
http://dx.doi.org/10.2967/jnumed.123.265433

Ejemplares similares